The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens

  14 September 2022

This article intends to collate and discuss the potential of 4D’s (right Drug, Dose, Duration and De-escalation of therapy) approach to tackle the emerging problem of AMR. For this, we searched PubMed, Google Scholar, Medline, and clinicaltrials.gov databases primarily using the keywords “optimal antibiotic therapy”, “antimicrobial resistance”, “higher versus lower dose antibiotic treatment”, “shorter versus longer duration antibiotic treatment”, “de-escalation study” and “antimicrobial stewardship measures” and based on the findings, form and expressed our opinion.

Further reading: Taylor & Francis Online
Author(s): Lovnish Thakur et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed